CTLA4 and neoplasm: We aimed to suppress the immunosuppressive signaling from the checkpoint CTLA-4/B7 axis using LPS-Nb36 and induce more efficient tumor-specific CTLs using the comprehensive DC-tumor fusion vaccine technology, thereby achieving superior antitumor functions of adoptive immunotherapy.